Westlake Chemical Corporation - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Westlake Chemical Corporation on March 20, 2006. The report discloses the entry into a material definitive agreement regarding executive compensation under the Company's 2004 Omnibus Incentive Plan.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of stock-based awards granted to named executive officers.
Material Changes and Executive Awards
On March 20, 2006, the Board of Directors approved the grant of restricted stock and stock options to six named executive officers. The specific awards are detailed below:
| Name | Title | Stock Options (Shares) | Restricted Stock (Shares) |
|---|---|---|---|
| Albert Chao | President and CEO | 9,514 | 5,794 |
| James Chao | Chairman of the Board | 6,977 | 4,249 |
| Wayne D. Morse | SVP, Vinyls | 1,903 | 1,159 |
| Stephen Wallace | VP, General Counsel & Secretary | 1,388 | 845 |
| Warren W. Wilder | VP, Olefins and Styrene | 1,269 | 773 |
| David R. Hansen | SVP, Administration | 1,522 | 927 |
Terms, Outlook, and Risks
- Restricted Stock Vesting: Shares vest in three equal installments of 33-1/3% on March 15, 2007, 2008, and 2009, subject to continuous employment. Holders receive dividends and voting rights during the vesting period.
- Stock Option Terms: The exercise price is set at $36.10, based on the average high and low trading prices on March 15, 2006. Options vest in four equal installments of 25% annually from March 15, 2007, through 2010, and expire on March 15, 2016.
- Management Commentary: The filing contains no forward-looking guidance, risk factors, or unusual items beyond the standard disclosure of the compensation agreement.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2004 Omnibus Incentive Plan to assess remaining capacity for future grants.
- Confirm the current market price of Westlake Chemical stock relative to the $36.10 exercise price to evaluate the intrinsic value of the options.
- Review the Company's subsequent filings (e.g., 10-K or 10-Q) for the actual financial impact of these awards on compensation expenses.
- Check for any changes in employment status of the named officers that would affect the vesting schedule.